The Essential Mechanisms of Aging: What Have We Learnt in Ten Years?

被引:7
作者
Yin, Dazhong [1 ,2 ]
机构
[1] Guangzhou Med Univ, Hosp 6, Qingyuan 511518, Guangdong, Peoples R China
[2] Hunan Normal Univ, Key Lab Prot Chem & Dev Biol, Minist Educ, Coll Life Sci, Changsha 410081, Hunan, Peoples R China
关键词
Aging mechanisms; Carbonyl stress; Entropy; Functional group; Life code; Neurobiochemistry; FREE-RADICAL THEORY; OXIDATIVE STRESS HYPOTHESIS; ALZHEIMERS-DISEASE; MAILLARD REACTION; CARBONYL STRESS; DIABETIC COMPLICATIONS; MOLECULAR-MECHANISMS; LIFE-SPAN; PROTEINS; LIPOFUSCIN;
D O I
10.2174/1568026615666150813142854
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Carbonylation due to oxidation and glycation is an important biochemical cause of degenerative diseases and aging. While the enigma of aging is understood as a result of molecular dysfunction due to the failure of maintenance systems, a brief history of the interpretation of aging mechanisms and the exact biochemistry connecting entropy and biological aging is addressed. Lipofuscin formation mechanisms resulting in irreparable accumulative changes represent the most important aging-related alterations of entropy increase in biological kingdom, which is very different from the damage-based "aging" process of inorganic materials. A fifth level of aging mechanism investigations that highlights the importance of functional groups of biochemistry, the "missing codes" of life science, is put forward in this review. Significance and validities of such 'life codes' in biology beyond genomic and proteomic concepts has also been clarified. An open-minded consideration of functional groups of biomolecules, such as carbonyl groups, may help to explain the mechanisms of fatigue and sleep in terms of neurobiochemistry and biological pharmaco-medicine.
引用
收藏
页码:503 / 510
页数:8
相关论文
共 50 条
  • [41] What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task Force
    Aisen, P. S.
    Siemers, E.
    Michelson, D.
    Salloway, S.
    Sampaio, C.
    Carrillo, M. C.
    Sperling, R.
    Doody, R.
    Scheltens, P.
    Bateman, R.
    Weiner, M.
    Vellas, B.
    Abushakr, Susan
    Amatniek, Joan
    Andrieu, Sandrine
    Bell, Joanne
    Bowman, Gene
    Bozeat, Sasha
    Haeberlein, Samantha Budd
    Cantillon, Marc
    Chuidian, Marither
    Cosma-Roman, Doina
    Cummings, Jeffrey
    De Jong-Laird, Anne
    Dube, Sanjay
    Egan, Michael
    Eggermont, Laura
    Ferrell, Phyllis
    Foff, Erin
    Fullerton, Terence
    Gouttefangeas, Sylvie
    Grundman, Michael
    Hendrix, Suzanne
    Hewitt, David
    Ho, Carole
    Kesslak, Patrick
    Legrand, Valerie
    Lind, Stefan
    Lyketsos
    Margolin, Richard
    Megerian, Thomas
    Merdes, Annette
    Michelson, David
    Mintun, Mark
    Mintzer, Jacobo
    Olsson, Tina
    Petersen, Ronald
    Podhorna, Jana
    Pollentier, Stephane
    Porsteinsson, Anton
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2018, 5 (03): : 171 - 183
  • [42] Secrets of platelet exocytosis - what do we really know about platelet secretion mechanisms?
    Golebiewska, Ewelina M.
    Poole, Alastair W.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (02) : 204 - 216
  • [43] On the Pathogenesis and Neuroprotective Treatment of Parkinson Disease: What have we Learned from the Genetic Forms of this Disease?
    Mena, M. A.
    Rodriguez-Navarro, J. A.
    Ros, R.
    de Yebenes, J. G.
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (23) : 2305 - 2320
  • [44] What have worm models told us about the mechanisms of neuronal dysfunction in human neurodegenerative diseases?
    Teschendorf, Dawn
    Link, Christopher D.
    MOLECULAR NEURODEGENERATION, 2009, 4
  • [45] Mental Training for Cognitive Improvement in Elderly People: What have We Learned from Clinical and Neurophysiologic Studies?
    Li, Bin-Yin
    Tang, Hui-Dong
    Qiao, Yuan
    Chen, Sheng-Di
    CURRENT ALZHEIMER RESEARCH, 2015, 12 (06) : 543 - 552
  • [46] What have we learned recently from transgenic mouse models about neurodegeneration? The most promising discoveries of this millennium
    Kreiner, Grzegorz
    PHARMACOLOGICAL REPORTS, 2018, 70 (06) : 1105 - 1115
  • [47] Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models?
    Marchetti, Cristina
    Marie, Helene
    REVIEWS IN THE NEUROSCIENCES, 2011, 22 (04) : 373 - 402
  • [48] Vagus nerve stimulation...25 years later! What do we know about the effects on cognition?
    Vonck, Kristl
    Raedt, Robrecht
    Naulaerts, Joke
    De Vogelaere, Frederick
    Thiery, Evert
    Van Roost, Dirk
    Aldenkamp, Bert
    Miatton, Marijke
    Boon, Paul
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2014, 45 : 63 - 71
  • [49] Mental Health of People with Dementia During COVID-19 Pandemic: What Have We Learned from the First Wave?
    Borg, Celine
    Rouch, Isabelle
    Pongan, Elodie
    Getenet, Jean Claude
    Bachelet, Romain
    Herrmann, Mathieu
    Bohec, Anne-Lise
    Laurent, Bernard
    Rey, Romain
    Dorey, Jean-Michel
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 82 (04) : 1531 - 1541
  • [50] What do we know about eye movements in Alzheimer's disease? The past 37 years and future directions
    Coubard, Olivier A.
    BIOMARKERS IN MEDICINE, 2016, 10 (07) : 677 - 680